Predicting events in clinical trials using two time-to-event outcomes

被引:0
|
作者
Mu, Rongji [1 ,2 ]
Xu, Jin [1 ]
机构
[1] East China Normal Univ, Sch Stat, Shanghai 200241, Peoples R China
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
基金
中国国家自然科学基金;
关键词
change point; convolution; event prediction; overall survival; progression-free survival; PROGRESSION-FREE SURVIVAL; SURROGATE; HAZARD; MODEL; ASSOCIATION; DEPENDENCE;
D O I
10.1002/bimj.201700083
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In clinical trials with time-to-event outcomes, it is of interest to predict when a prespecified number of events can be reached. Interim analysis is conducted to estimate the underlying survival function. When another correlated time-to-event endpoint is available, both outcome variables can be used to improve estimation efficiency. In this paper, we propose to use the convolution of two time-to-event variables to estimate the survival function of interest. Propositions and examples are provided based on exponential models that accommodate possible change points. We further propose a new estimation equation about the expected time that exploits the relationship of two endpoints. Simulations and the analysis of real data show that the proposed methods with bivariate information yield significant improvement in prediction over that of the univariate method.
引用
收藏
页码:815 / 826
页数:12
相关论文
共 50 条
  • [1] A hybrid approach to predicting events in clinical trials with time-to-event outcomes
    Fang, Liang
    Su, Zheng
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (05) : 755 - 759
  • [2] Predicting analysis time in events-driven clinical trials using accumulating time-to-event surrogate information
    Wang, Jianming
    Ke, Chunlei
    Yu, Zhinuan
    Fu, Lei
    Dornseif, Bruce
    PHARMACEUTICAL STATISTICS, 2016, 15 (03) : 198 - 207
  • [3] Projection of power and events in clinical trials with a time-to-event outcome
    Royston, Patrick
    Barthel, Friederike M-S
    STATA JOURNAL, 2010, 10 (03): : 386 - 394
  • [4] Predicting study duration in clinical trials with a time-to-event endpoint
    Machida, Ryunosuke
    Fujii, Yosuke
    Sozu, Takashi
    STATISTICS IN MEDICINE, 2021, 40 (10) : 2413 - 2421
  • [5] A Bayesian approach for event predictions in clinical trials with time-to-event outcomes
    Aubel, Paul
    Antigny, Marine
    Fougeray, Ronan
    Dubois, Frederic
    Saint-Hilary, Gaelle
    STATISTICS IN MEDICINE, 2021, 40 (28) : 6344 - 6359
  • [6] A Bayesian Sequential Design for Clinical Trials With Time-to-Event Outcomes
    Zhu, Lin
    Yu, Qingzhao
    Mercante, Donald E.
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2019, 11 (04): : 387 - 397
  • [7] Assurance calculations for planning clinical trials with time-to-event outcomes
    Ren, Shijie
    Oakley, Jeremy E.
    STATISTICS IN MEDICINE, 2014, 33 (01) : 31 - 45
  • [8] Efficient group-sequential designs for monitoring two time-to-event outcomes in clinical trials
    Hamasaki, Toshimitsu
    Asakura, Koko
    Sugimoto, Tomoyuki
    Evans, Scott R.
    Yamamoto, Haruko
    Hsiao, Chin-Fu
    TRIALS, 2017, 18
  • [9] Sizing clinical trials when comparing bivariate time-to-event outcomes
    Sugimoto, Tomoyuki
    Hamasaki, Toshimitsu
    Evans, Scott R.
    Sozu, Takashi
    STATISTICS IN MEDICINE, 2017, 36 (09) : 1363 - 1382
  • [10] Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes
    Uno, Hajime
    Schrag, Deborah
    Kim, Dae Hyun
    Tang, Dejun
    Tian, Lu
    Rugo, Hope S.
    Wei, Lee-Jen
    JNCI CANCER SPECTRUM, 2019, 3 (04)